PERampanel Shows High Success in Treating Epilepsy Alone
A study called the MonoPER study looked at how effective and tolerable the medication Perampanel (PER) is when used alone to treat adults with focal or idiopathic generalized epilepsy.
Epilepsy genetics explained: Explore epilepsy genetics in plain language. What key genes mean, how testing works, and what families should know.
A study called the MonoPER study looked at how effective and tolerable the medication Perampanel (PER) is when used alone to treat adults with focal or idiopathic generalized epilepsy.
A recent study looked at two different treatments for people with epilepsy caused by a brain condition called focal cortical dysplasia (FCD) that shows up on MRI scans.
Researchers studied the effectiveness of five newer anti-seizure medications (ASMs) in treating Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that begins in childhood and is often resistant to treatment.
Researchers studied a specific type of epilepsy linked to mutations in the KCNT1 gene, which causes potassium channels in the brain to become overly active.
This study focused on late-onset epilepsy (LOE), which occurs in people over the age of 50, and the challenges in diagnosing its causes.
This study looked at how doctors who treat epilepsy in Malaysia view a new digital service designed to predict seizures based on heart activity.
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
This study looked at how neurologists in five European countriesβUK, Norway, Sweden, Spain, and Hungaryβcommunicate about Sudden Unexpected Death in Epilepsy (SUDEP), which is a major cause of death for people with epilepsy.
Researchers studied the challenges that healthcare providers face when trying to follow guidelines for genetic testing and counseling in people with epilepsy.